Greenwich LifeSciences (GLSI) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Greenwich LifeSciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $577K and 0 sold $0 of GLSI stock on the open market.
Get emailed when insiders cluster-buy stocks like GLSI
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
GLSI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $97K | 5 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $134K | 2 | — | 0 |
| Q4 2025 | $356K | 6 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Greenwich LifeSciences, Inc. insider reported open-market purchases totaling $577K, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Snehal Patel (CEO, CFO) has the highest Insider Score at 100.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jul 30SEC | Snehal PatelCEO, CFO | Buy | 1,5005,610,702 held (+0%) | $13.59 | $20K | +21.6% | 100 |
| Jul 30SEC | Snehal PatelCEO, CFO | Buy | 7005,611,402 held (+0%) | $13.10 | $9K | +26.2% | 100 |
| Jul 29SEC | Snehal PatelCEO, CFO | Buy | 1,5005,609,202 held (+0%) | $13.62 | $20K | +21.4% | 100 |
| Jul 27SEC | Snehal PatelCEO, CFO | Buy | 2,5005,606,602 held (+0%) | $13.14 | $33K | +25.8% | 100 |
| Jul 27SEC | Snehal PatelCEO, CFO | Buy | 1,1005,607,702 held (+0%) | $12.88 | $14K | +28.3% | 100 |
| Jan 15SEC | Snehal PatelCEO, CFO | Buy | 1,8005,604,102 held (+0%) | $29.83 | $54K | -44.6% | 100 |
| Jan 14SEC | Snehal PatelCEO, CFO | Buy | 2,9005,602,302 held (+0%) | $27.54 | $80K | -40.0% | 100 |
| Jan 5SEC | Snehal PatelCEO, CFO | Buy | 4,3005,599,402 held (+0%) | $21.36 | $92K | -22.6% | 100 |
| Jan 2SEC | Snehal PatelCEO, CFO | Buy | 2,9005,595,102 held (+0%) | $21.73 | $63K | -23.9% | 100 |
| Dec 19SEC | Snehal PatelCEO, CFO | Buy | 4,1005,592,202 held (+0%) | $12.62 | $52K | +31.0% | 100 |
| Nov 28SEC | Snehal PatelCEO, CFO | Buy | 4,6005,588,102 held (+0%) | $8.37 | $39K | +97.5% | 100 |
| Nov 12SEC | Snehal PatelCEO, CFO | Buy | 10,6005,583,502 held (+0%) | $8.43 | $89K | +96.1% | 100 |
| Nov 4SEC | Snehal PatelCEO, CFO | Buy | 2,3005,572,902 held (+0%) | $9.26 | $21K | +78.5% | 100 |
Insiders at Greenwich LifeSciences, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Snehal PatelCEO, CFO | $586K | — | Jul 30, 2026 | 100 |
GLSI stock: common questions
Are Greenwich LifeSciences, Inc. insiders buying GLSI stock?
In the past 12 months, 1 insiders reported open-market purchases of GLSI worth $577K. The latest was CEO, CFO Snehal Patel bought $20K of GLSI at $13.59.
Are Greenwich LifeSciences, Inc. insiders selling GLSI stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is GLSI's 52-week range?
Over the past year GLSI has traded between $7.85 and $33.56. It last closed at $16.53 on Oct 9, 2026.